Library

Displaying 1,151 - 1,175 of 2,412

Case Presentation: CLL

Case Presentation: CLL

By: Luis A. Velazquez, MD

Novel Therapeutic Strategies in Acute Myeloid Leukemia: Our Cup Runneth Over

Novel Therapeutic Strategies in Acute Myeloid Leukemia: Our Cup Runneth Over

By: Martin S Tallman - MD

De Novo Acute Myeloid Leukemia

De Novo Acute Myeloid Leukemia

By: Martin S. Tallman, MD

Novel Therapeutic Strategies in Acute Myeloid Leukemia Our Cup Runneth Over

Novel Therapeutic Strategies in Acute Myeloid Leukemia Our Cup Runneth Over

By: Martin S. Tallman, MD

A Cure For (Almost) Every Patient With APL

A Cure For (Almost) Every Patient With APL

By: Martin S. Tallman, MD

Acute Myeloid Leukemia

Acute Myeloid Leukemia

By: Martin Tallman, MD

Acute Myeloid Leukemia

Acute Myeloid Leukemia

By: Martin Tallman, MD

Myelodysplastic Syndromes Is It Time to Incorporate NGS and What Is New in Terms of Therapy

Myelodysplastic Syndromes Is It Time to Incorporate NGS and What Is New in Terms of Therapy

By: Rami Komrokji, MD

De Novo Acute Myeloid Leukemia

De Novo Acute Myeloid Leukemia

By: Rami Komrokji, MD

De Novo Acute Myeloid Leukemia

De Novo Acute Myeloid Leukemia

By: Richard Stone, MD

De Novo Acute Myeloid Leukemia

De Novo Acute Myeloid Leukemia

By: Richard Stone, MD

Update on Therapy Options for Untreated and Relapsed CLL

Update on Therapy Options for Untreated and Relapsed CLL

By: Scott Huntington, MD, MPH

Learning from BTK Inhibitors & Moving Forward the Therapeutic Field in CLL

Learning from BTK Inhibitors & Moving Forward the Therapeutic Field in CLL

By: William G. Wierda, MD, PhD

Learning from BTK Inhibitors & Moving Forward the Therapeutic Field in CLL

Learning from BTK Inhibitors & Moving Forward the Therapeutic Field in CLL

By: William G. Wierda, MD, PhD

Case Presentation: Acute Leukemia

Case Presentation: Acute Leukemia

By: William Marrero, MD

Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

By: William Wierda, MD, PhD

Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

By: William Wierda, MD, PhD

Advances in Cellular Therapy

Advances in Cellular Therapy

By: Mehrdad Abedi, MD

Management of Patients After CAR-T Therapy: Adverse Reactions and Follow Up

Management of Patients After CAR-T Therapy: Adverse Reactions and Follow Up

By: Brigett Brandjes, PA-C, MMSc

Liquid Biopsies to Guide Targeted Therapy

Liquid Biopsies to Guide Targeted Therapy

By: Bruna Pellini, MD

Liquid Biopsy and Precision Oncology

Liquid Biopsy and Precision Oncology

By: Christian Rolfo, MD

Novel Platforms to Assess the Cancer Continuom Using Liquid Biopsy

Novel Platforms to Assess the Cancer Continuom Using Liquid Biopsy

By: Christian Rolfo, MD, PhD, MBA, Dr.h.c.

Novel Platforms to Assess the Cancer Continuom Using Liquid Biopsy

Novel Platforms to Assess the Cancer Continuom Using Liquid Biopsy

By: Christian Rolfo, MD, PhD, MBA, Dr.h.c.

Convergence of Liquid Biopsy and Precision Oncology in the Management of NSCLC

Convergence of Liquid Biopsy and Precision Oncology in the Management of NSCLC

By: David Gandara, MD & Jonathan W. Riess, MD, MS

Convergence of Liquid Biopsy and Precision Oncology in the Management of NSCLC

Convergence of Liquid Biopsy and Precision Oncology in the Management of NSCLC

By: David Gandara, MD & Jonathan W. Riess, MD, MS